158 related articles for article (PubMed ID: 28356444)
21. [Inhibitory effect of insulin-like growth factor binding protein-related protein 1 on retinal angiogenesis via ERK signaling pathway].
Zhang P; Wang H; Cao H; Xu X; Sun T
Zhonghua Yan Ke Za Zhi; 2017 Mar; 53(3):207-211. PubMed ID: 28316197
[No Abstract] [Full Text] [Related]
22. Thioredoxin-interacting protein deficiency ameliorates diabetic retinal angiogenesis.
Duan J; Du C; Shi Y; Liu D; Ma J
Int J Biochem Cell Biol; 2018 Jan; 94():61-70. PubMed ID: 29203232
[TBL] [Abstract][Full Text] [Related]
23. TSPAN12 regulates retinal vascular development by promoting Norrin- but not Wnt-induced FZD4/beta-catenin signaling.
Junge HJ; Yang S; Burton JB; Paes K; Shu X; French DM; Costa M; Rice DS; Ye W
Cell; 2009 Oct; 139(2):299-311. PubMed ID: 19837033
[TBL] [Abstract][Full Text] [Related]
24. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.
Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470
[TBL] [Abstract][Full Text] [Related]
25. Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease.
Wang W; LeBlanc ME; Chen X; Chen P; Ji Y; Brewer M; Tian H; Spring SR; Webster KA; Li W
Angiogenesis; 2017 Nov; 20(4):479-492. PubMed ID: 28447229
[TBL] [Abstract][Full Text] [Related]
26. The mechanism of CCN1-enhanced retinal neovascularization in oxygen-induced retinopathy through PI3K/Akt-VEGF signaling pathway.
Di Y; Zhang Y; Yang H; Wang A; Chen X
Drug Des Devel Ther; 2015; 9():2463-73. PubMed ID: 25995618
[TBL] [Abstract][Full Text] [Related]
27. Evogliptin, a dipeptidyl peptidase-4 inhibitor, attenuates pathological retinal angiogenesis by suppressing vascular endothelial growth factor-induced Arf6 activation.
Seo S; Kim MK; Kim RI; Yeo Y; Kim KL; Suh W
Exp Mol Med; 2020 Oct; 52(10):1744-1753. PubMed ID: 33051573
[TBL] [Abstract][Full Text] [Related]
28. Persistent inhibition of oxygen-induced retinal neovascularization by anthrax lethal toxin.
Bromberg-White JL; Boguslawski E; Hekman D; Kort E; Duesbery NS
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8979-92. PubMed ID: 21989728
[TBL] [Abstract][Full Text] [Related]
29. Glycogen-Synthase Kinase3beta/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells.
Skurk C; Maatz H; Rocnik E; Bialik A; Force T; Walsh K
Circ Res; 2005 Feb; 96(3):308-18. PubMed ID: 15662032
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of neovascularization and expression shift of pro-/anti-angiogenic vascular endothelial growth factor isoforms after intravitreal bevacizumab injection in oxygen-induced-retinopathy mouse model.
Shi X; Zhao M; Xie WK; Liang JH; Miao YF; DU W; Li XX
Chin Med J (Engl); 2013 Jan; 126(2):345-52. PubMed ID: 23324288
[TBL] [Abstract][Full Text] [Related]
31. Knockout of αA-crystallin inhibits ocular neovascularization.
Xu Q; Bai Y; Huang L; Zhou P; Yu W; Zhao M
Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):816-26. PubMed ID: 25574047
[TBL] [Abstract][Full Text] [Related]
32. Anti-angiogenic effect of luteolin on retinal neovascularization via blockade of reactive oxygen species production.
Park SW; Cho CS; Jun HO; Ryu NH; Kim JH; Yu YS; Kim JS; Kim JH
Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7718-26. PubMed ID: 23099493
[TBL] [Abstract][Full Text] [Related]
33. Antiangiogenesis effects of endostatin in retinal neovascularization.
Bai YJ; Huang LZ; Zhou AY; Zhao M; Yu WZ; Li XX
J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016
[TBL] [Abstract][Full Text] [Related]
34. Norrin mediates angiogenic properties via the induction of insulin-like growth factor-1.
Zeilbeck LF; Müller BB; Leopold SA; Senturk B; Langmann T; Tamm ER; Ohlmann A
Exp Eye Res; 2016 Apr; 145():317-326. PubMed ID: 26706283
[TBL] [Abstract][Full Text] [Related]
35. SZN-413, a FZD4 Agonist, as a Potential Novel Therapeutic for the Treatment of Diabetic Retinopathy.
Nguyen H; Chen H; Vuppalapaty M; Whisler E; Logas KR; Sampathkumar P; Fletcher RB; Sura A; Suen N; Gupta S; Lopez T; Ye J; Tu S; Bolaki M; Yeh WC; Li Y; Lee SJ
Transl Vis Sci Technol; 2022 Sep; 11(9):19. PubMed ID: 36149648
[TBL] [Abstract][Full Text] [Related]
36. Silencing of galectin-1 inhibits retinal neovascularization and ameliorates retinal hypoxia in a murine model of oxygen-induced ischemic retinopathy.
Yang N; Zhang W; He T; Xing Y
Exp Eye Res; 2017 Jun; 159():1-15. PubMed ID: 28257831
[TBL] [Abstract][Full Text] [Related]
37. Interferon-γ inhibits retinal neovascularization in a mouse model of ischemic retinopathy.
Jung I; Jung D; Zha Z; Jeong J; Noh S; Shin J; Park JK; Kim KS; Jeong Y; Hur J; Baek MC; Diaz-Aguilar S; Aguilar E; Friedlander M; Bucher F; Yea K
Cytokine; 2021 Jul; 143():155542. PubMed ID: 33926775
[TBL] [Abstract][Full Text] [Related]
38. The potential effect of human chorionic gonadotropin on vasoproliferative disorders of the immature retina.
Movsas TZ; Muthusamy A
Neuroreport; 2018 Dec; 29(18):1525-1529. PubMed ID: 30300333
[TBL] [Abstract][Full Text] [Related]
39. SCF (Stem Cell Factor) and cKIT Modulate Pathological Ocular Neovascularization.
Kim KL; Seo S; Kim JT; Kim J; Kim W; Yeo Y; Sung JH; Park SG; Suh W
Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):2120-2131. PubMed ID: 31434494
[TBL] [Abstract][Full Text] [Related]
40. Cysteine-rich 61, a member of the CCN family, as a factor involved in the pathogenesis of proliferative diabetic retinopathy.
You JJ; Yang CH; Chen MS; Yang CM
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3447-55. PubMed ID: 19264885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
